Enter assignee name

% Expired Patents = 66.7

Forward Citations = 4

Loading Chart...

11 inventors (with patents filed for the assignee):

Vladimir Khazak (4 out of 11 patents)

Igor Astsaturov (2 out of 4 patents)

Chung Shih (2 out of 12 patents)

4. Christoph Burdack (2 out of 4 patents)

5. Lutz Weber (2 out of 16 patents)

6. Ilya G Serebriiskii (1 out of 8 patents)

7. Ilya Serebriiski (1 out of 1 patent)

8. Cedric Kalinski (1 out of 3 patents)

9. Gunther Ross (1 out of 3 patents)

10. Cotïc Kalinski (1 out of 1 patent)

11. Günther F Ross (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 10328050 - C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition (2019-06-25),

2. 9993458 - Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors (2018-06-12),

3. 9149530 - Compositions and methods for enhancing active agent absorption (2015-10-06),

4. 8426466 - Compositions and methods for enhancing active agent absorption (2013-04-23),

5. 8367699 - Tetrahydro-isoquinolines (2013-02-05),

6. 8163744 - Tetrahydro-isoquinolin-1-ones for the treatment of cancer (2012-04-24),

Nexuspharma, Inc. is a leading pharmaceutical company dedicated to improving healthcare through innovative products and solutions. With a focus on research and development, Nexuspharma is committed to providing high-quality medications that meet the needs of patients worldwide. Our experienced team of scientists and healthcare professionals work tirelessly to bring new treatments to market and improve outcomes for patients. Visit our website to learn more about our company and our products.

This text is generated by artificial intelligence and may not be accurate.